1.
Evaluating The Safety Profile Of Nintedanib Among ILD Patients In A Tertiary Care Hospital: A Prospective Research Approach Focusing On Adverse Drug Reactions. Int. J. Environ. Sci. Published online October 8, 2025:5496-5502. doi:10.64252/69nwp181